As of 2025-12-23, the Fair Value of Fate Therapeutics Inc (FATE) is -6.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.05 USD, the upside of Fate Therapeutics Inc is -744.39%.
With the market price of 1.05 USD and our fair value calculation, Fate Therapeutics Inc (FATE) is not a good investment. Investing in FATE stocks now will result in a potential loss of 744.39%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -173.39 | -212.15 | -281.72 | -160.93 | -186.26 | -202.89 |
| YoY growth | -76.66% | -22.35% | -32.79% | 42.88% | -15.74% | -20.93% |
| Market Cap (mil) | 121.12 |
| P/E | |
| Forward P/E |
| EPS | -1.35 |
| Avg earnings growth rate | -20.93% |
| TTM earnings | -156.09 |